EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

P2Y12 Inhibitor Monotherapy for Secondary Stroke Prevention: Comparative Outcomes of Clopidogrel, Ticagrelor, and Prasugrel

Ahmed Khalil, Louie Kamel-Abusalha, Khaled Gharaibeh, Adam Mierzwa, Hisham Alhajala, Fouad Bouso, Hashir Faheem, Rayan Muhsen, Kirollos Tadrousse, Alan Fahoury, Syed Owais, Mouhammad Jumaa und 1 weitere

Stroke: Vascular and Interventional Neurology · 02.11.2026

DOI: 10.1161/svin.125.002193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, online erschienen am 02.11.2026. Verfasst von Ahmed Khalil und 12 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ticagrelor and prasugrel have shown greater efficacy than clopidogrel in acute coronary syndromes; yet, direct comparisons of these agents as monotherapy for secondary stroke prevention remain limited. METHODS: Adults with a prior cerebral infarction who received clopidogrel, ticagrelor, or prasugrel were identified from the TriNetX Research Network. Two separate 1:1 propensity-score–matched comparisons were conducted: clopidogrel versus ticagrelor (n=6144 per group) and clopidogrel versus prasugrel (n=1037 per group). Clinical outcomes at 1 month and 1 year included all-cause mortality, hemorrhagic stroke, acute kidney injury, blood transfusion, and seizures. RESULTS: At both 1 month and 1 year, clopidogrel was associated with significantly lower all-cause mortality versus ticagrelor ( P

Zitieren

APA

Khalil, A., Kamel-Abusalha, L., Gharaibeh, K., Mierzwa, A., Alhajala, H., Bouso, F., Faheem, H., Muhsen, R., Tadrousse, K., Fahoury, A., Owais, S., Jumaa, M., & Zaidi, S. (2026). P2Y12 Inhibitor Monotherapy for Secondary Stroke Prevention: Comparative Outcomes of Clopidogrel, Ticagrelor, and Prasugrel. Stroke: Vascular and Interventional Neurology. https://doi.org/10.1161/svin.125.002193

Vancouver

Khalil A, Kamel-Abusalha L, Gharaibeh K, Mierzwa A, Alhajala H, Bouso F, et al. P2Y12 Inhibitor Monotherapy for Secondary Stroke Prevention: Comparative Outcomes of Clopidogrel, Ticagrelor, and Prasugrel. Stroke: Vascular and Interventional Neurology. 2026. doi:10.1161/svin.125.002193

BibTeX
@article{Khalil2026,
  author = {Khalil, Ahmed and Kamel-Abusalha, Louie and Gharaibeh, Khaled and Mierzwa, Adam and Alhajala, Hisham and Bouso, Fouad and Faheem, Hashir and Muhsen, Rayan and Tadrousse, Kirollos and Fahoury, Alan and Owais, Syed and Jumaa, Mouhammad and Zaidi, Syed},
  title = {P2Y12 Inhibitor Monotherapy for Secondary Stroke Prevention: Comparative Outcomes of Clopidogrel, Ticagrelor, and Prasugrel},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2026},
  doi = {10.1161/svin.125.002193}
}
Kostenlos starten →